Earnings History Data for SAB Biotherapeutics, Inc. (SABS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

SAB Biotherapeutics, Inc.

SAB Biotherapeutics Inc. is a clinical-stage biopharmaceutical company advancing a new class of immunotherapies leveraging fully human polyclonal antibodies. It produces natural, specifically targeted, high-potency, human polyclonal immunotherapies. SAB Biotherapeutics Inc., formerly known as Big Cypress Acquisition Corp., is based in SIOUX FALLS, S.D.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
13-11-2023 PM SABS SAB Biotherapeutics 50.00 -0.10 -0.10 0.00 SAB Biotherapeutics GAAP EPS of -$0.10
[11/14/2023 9:25 AM]
0.92 -0.01 
(-1.08%)
0.86 -0.07 
(-7.58%)
0.37 - 1.45 13,450 60,000 4,350
21-08-2023 PM SABS SAB Biotherapeutics 41.00 -0.14 -0.16 0.00 0.7690 0.01 
(1.05%)
0.76 0.0 
(0.03%)
0.37 - 1.45 57,980 20,000 3,344
16-05-2023 PM SABS SAB Biotherapeutics 47.00 -0.15 -0.08 0.00 SAB Biotherapeutics GAAP EPS of -$0.15
[5/16/2023 9:18 AM]
0.7799 -0.10 
(-11.38%)
0.81 -0.07 
(-7.77%)
0.37 - 2.31 221,171 1,120,000 5,726
15-11-2022 PM SABS SAB Biotherapeutics 49.00 -0.16 -0.14 0.00 SAB Biotherapeutics GAAP EPS of -$0.16 misses by $0.02
[11/15/2022 8:59 AM]
1.08 -0.17 
(-13.61%)
1.25 0.0 
(0.00%)
0.62 - 12.09 91,417 90,000 18,114
10-08-2022 PM SABS SAB Biotherapeutics 53.00 -0.11 -0.13 0.00 SAB Biotherapeutics GAAP EPS of -$0.11 beats by $0.03
[8/10/2022 8:22 AM]
1.12 -0.03 
(-2.61%)
1.14 -0.01 
(-0.87%)
1.00 - 12.90 53,551 50,000 174
12-05-2022 AH After the close
(May 12)
SABS SAB Biotherapeutics 86.00 -0.15 -0.12 0.00 SAB Biotherapeutics GAAP EPS of $0.02
[5/12/2022 5:11 PM]
1.96 0.17 
(9.66%)
0.0 0.0 
(0.00%)
1.61 - 12.90 32,884 40,000 0